Back
BioXcel Therapeutics Stock Price Chart
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager
Sell
17
BTAI
BioXcel Therapeutics
Last Price:
0.67
Seasonality Move:
-17.9%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is relatively stagnant and BTAI is experiencing slight buying pressure.
BioXcel Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.6 | Buy |
| 20-day SMA: | 0.62 | Buy |
| 50-day SMA: | 0.85 | Sell |
| 200-day SMA: | 2.14 | Sell |
| 8-day EMA: | 0.61 | Buy |
| 20-day EMA: | 0.64 | Sell |
| 50-day EMA: | 0.86 | Sell |
| 200-day EMA: | 2.79 | Sell |
BioXcel Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 43.9 | Sell |
| Chaikin Money Flow: | -188116 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
BioXcel Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioXcel Therapeutics Stock
Is BioXcel Therapeutics Stock a Buy?
- BioXcel Therapeutics share price is 0.64 while BTAI 8-day simple moving average is 0.60, which is a Buy signal.
- The stock price of BTAI is 0.64 while BioXcel Therapeutics 20-day SMA is 0.62, which makes it a Buy.
- BioXcel Therapeutics 50-day simple moving average is 0.85 while BTAI share price is 0.64, making it a Sell technically.
- BTAI stock price is 0.64 and BioXcel Therapeutics 200-day simple moving average is 2.14, creating a Sell signal.
BTAI Technical Analysis vs Fundamental Analysis
Sell
17
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy or a Sell?
-
BioXcel Therapeutics stock is rated a Sell
The current BioXcel Therapeutics [BTAI] share price is $0.64. The Score for BTAI is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
BioXcel Therapeutics Stock Info
Market Cap:
25.87M
Price in USD:
0.64
Share Volume:
254.25K
BioXcel Therapeutics 52-Week Range
52-Week High:
5.62
52-Week Low:
0.53
Sell
17
BioXcel Therapeutics (BTAI)
is a Sell
BioXcel Therapeutics Share Price Forecast
-
What is the BioXcel Therapeutics stock price today?
The BioXcel Therapeutics stock price is 0.64 USD today. -
Will BTAI stock go up or go down?
BioXcel Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is BioXcel Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioXcel Therapeutics is overvalued.
Is BioXcel Therapeutics Stock a Buy?
- BioXcel Therapeutics share price is 0.64 while BTAI 8-day exponential moving average is 0.61, which is a Buy signal.
- The stock price of BTAI is 0.64 while BioXcel Therapeutics 20-day EMA is 0.64, which makes it a Sell.
- BioXcel Therapeutics 50-day exponential moving average is 0.86 while BTAI share price is 0.64, making it a Sell technically.
- BTAI stock price is 0.64 and BioXcel Therapeutics 200-day simple moving average is 2.79, creating a Sell signal.
Fundamental Analysis of BioXcel Therapeutics
Is BioXcel Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.81 per share, an increase next quarter of $0.12 per share, an increase this year of $4.08 per share, and an increase next year of $0.47 per share.
Technical Analysis of BioXcel Therapeutics
Should I short BioXcel Therapeutics stock?
- BTAI Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting BioXcel Therapeutics is a Sell
- BioXcel Therapeutics Relative Strength Index (RSI) is 43.9, which suggest BioXcel Therapeutics is oversold
- The Bollinger Bands (25) for BioXcel Therapeutics is ( - ), which suggest BioXcel Therapeutics is a Buy
- The Bollinger Bands (100) for BioXcel Therapeutics is ( - ), which suggest BioXcel Therapeutics is a Buy
* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.